Recommendations for hematologists in COVID-19 crisis
COVID-19, caused by SARS-CoV-2, is expected to be a devastating infection in many patients with hematologic diseases. It should be taken seriously and managed rigorously without jeopardizing the curative chance of individual patients.
Please note that these recommendations express expert opinions but should not be regarded as formal guidelines.
FAQ by EHA Scientific Working Group Infections in Hematology
In view of the rapidly changing evidence and general situation, the EHA Scientific Working Group Infections in Hematology has developed key questions and answers on the management of cancer patients with or at risk of COVID-19.
Recommendations for specific hematologic malignancies
EHA SWGs are providing recommendations regarding COVID-19 and specific hematologic malignancies.
Recommendations for specific non-malignant hematologic diseases
Collection of expert recommendations regarding COVID-19 and specific non-malignant hematologic diseases.
COVID-19 - Impact on childhood hematology patients
The EHA SWG on pediatrics has analyzed the impact and the risk of COVID-19 on pediatric hematology patients.